Adherence Levels Similar Between Branded, Generic HIV Drugs

Among patients with HIV, adherence to antiretroviral therapy (ART) is key to viral suppression, while nonadherence has been linked to both drug resistance and disease progression.

With the introduction of single-tablet regimens (STRs) for ART, treatment regimens have been simplified, thereby increasing adherence compared with multi-tablet regimens (MTRs).

At this point in time, STRs for ART are only available as brand-name products. Studies demonstrated that switching patients from brand name STRs to MTRs that may include both brand and generic drugs could generate enormous cost savings. The biggest concern is that the cost savings from switching patients to cheap regimens could be offset by decreased adherence due to higher pill burden and frequency.

For more information, please visit MDMag.com.


Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Treatment with tezepelumab reduced annual asthma exacerbation rates in patients with severe asthma without an eosinophilic phenotype.
Gordon Vanscoy, PharmD, MBA, explains the challenges patients face when being treated with orphan drugs, and how pharmacists can help overcome these challenges.
Substituting brand name combination drugs for lower-cost generics could have reduced spending by $925 million in 2016.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$